ANI Pharmaceuticals, Inc. (ANIP)

Market Cap	1.31B
Revenue (ttm)	517.46M
Net Income (ttm)	33.92M
Shares Out	20.96M
EPS (ttm)	1.58
PE Ratio	39.65
Forward PE	14.44
Dividend	n/a
Ex-Dividend Date	n/a

Volume	102,879
Open	63.03
Previous Close	63.44
Day's Range	62.41 - 63.60
52-Week Range	48.20 - 70.81
Beta	0.81
Analysts	Strong Buy
Price Target	83.67 (+33.57%)
Earnings Date	Aug 7, 2024

About ANIP

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmac...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 642
• Stock Exchange: NASDAQ
• Ticker Symbol: ANIP

Analyst Forecast

According to 4 analysts, the average rating for ANIP stock is "Strong Buy." The 12-month stock price forecast is $83.67, which is an increase of 33.57% from the latest price.

Price Target

$83.67

(33.57% upside)

Analyst Consensus: Strong Buy